SUPPLY OF MEDICINES WITH ACTIVE INGREDIENTS CISATRACURIUM 2 MG/ML, PARENTERAL DEXKETOPROFEN, PARENTERAL FENTANYL, FLUMAZENIL, IRON SUCROSE, PARENTERAL LACOSAMIDE, LEVOSIMENDAN, NOREPINEPHRINE, MONTHLY INTRAMUSCULAR PALIPERIDONE, PARACETAMOL 1000 MG PARENTERAL, PROPOFOL 2%, PROPOFOL 1%, ROCURONIUM, SUGAMMADEX, BOTULINUM TOXIN TYPE A 50 UNITS, BOTULINUM TOXIN TYPE A 100 UNITS AND BOTULINUM TOXIN TYPE A 500 UNITS FOR THE CENTERS DEPENDENT ON THE MURCIAN HEALTH SERVICE.
CISATRACURIO 2 MG/ML 5 MLSUPPLY OF MEDICINES WITH ACTIVE INGREDIENTS CISATRACURIUM 2 MG/ML, PARENTERAL DEXKETOPROFEN, PARENTERAL FENTANYL, FLUMAZENIL, IRON SUCROSE, PARENTERAL LACOSAMIDE, LEVOSIMENDAN, NOREPINEPHRINE, MONTHLY INTRAMUSCULAR PALIPERIDONE, PARACETAMOL 1000 MG PARENTERAL, PROPOFOL 2%, PROPOFOL 1%, ROCURONIUM, SUGAMMADEX, BOTULINUM TOXIN TYPE A 50 UNITS, BOTULINUM TOXIN TYPE A 100 UNITS AND BOTULINUM TOXIN TYPE A 500 UNITS FOR THE CENTERS DEPENDENT ON THE MURCIAN HEALTH SERVICE.
PARACETAMOL 1000 MG PARENTERALSUPPLY OF MEDICINES WITH ACTIVE INGREDIENTS CISATRACURIUM 2 MG/ML, PARENTERAL DEXKETOPROFEN, PARENTERAL FENTANYL, FLUMAZENIL, IRON SUCROSE, PARENTERAL LACOSAMIDE, LEVOSIMENDAN, NOREPINEPHRINE, MONTHLY INTRAMUSCULAR PALIPERIDONE, PARACETAMOL 1000 MG PARENTERAL, PROPOFOL 2%, PROPOFOL 1%, ROCURONIUM, SUGAMMADEX, BOTULINUM TOXIN TYPE A 50 UNITS, BOTULINUM TOXIN TYPE A 100 UNITS AND BOTULINUM TOXIN TYPE A 500 UNITS FOR THE CENTERS DEPENDENT ON THE MURCIAN HEALTH SERVICE.
PROPOFOL 2%SUPPLY OF MEDICINES WITH ACTIVE INGREDIENTS CISATRACURIUM 2 MG/ML, PARENTERAL DEXKETOPROFEN, PARENTERAL FENTANYL, FLUMAZENIL, IRON SUCROSE, PARENTERAL LACOSAMIDE, LEVOSIMENDAN, NOREPINEPHRINE, MONTHLY INTRAMUSCULAR PALIPERIDONE, PARACETAMOL 1000 MG PARENTERAL, PROPOFOL 2%, PROPOFOL 1%, ROCURONIUM, SUGAMMADEX, BOTULINUM TOXIN TYPE A 50 UNITS, BOTULINUM TOXIN TYPE A 100 UNITS AND BOTULINUM TOXIN TYPE A 500 UNITS FOR THE CENTERS DEPENDENT ON THE MURCIAN HEALTH SERVICE.
Propofol 1%SUPPLY OF MEDICINES WITH ACTIVE INGREDIENTS CISATRACURIUM 2 MG/ML, PARENTERAL DEXKETOPROFEN, PARENTERAL FENTANYL, FLUMAZENIL, IRON SUCROSE, PARENTERAL LACOSAMIDE, LEVOSIMENDAN, NOREPINEPHRINE, MONTHLY INTRAMUSCULAR PALIPERIDONE, PARACETAMOL 1000 MG PARENTERAL, PROPOFOL 2%, PROPOFOL 1%, ROCURONIUM, SUGAMMADEX, BOTULINUM TOXIN TYPE A 50 UNITS, BOTULINUM TOXIN TYPE A 100 UNITS AND BOTULINUM TOXIN TYPE A 500 UNITS FOR THE CENTERS DEPENDENT ON THE MURCIAN HEALTH SERVICE.
ROCURONIUMSUPPLY OF MEDICINES WITH ACTIVE INGREDIENTS CISATRACURIUM 2 MG/ML, PARENTERAL DEXKETOPROFEN, PARENTERAL FENTANYL, FLUMAZENIL, IRON SUCROSE, PARENTERAL LACOSAMIDE, LEVOSIMENDAN, NOREPINEPHRINE, MONTHLY INTRAMUSCULAR PALIPERIDONE, PARACETAMOL 1000 MG PARENTERAL, PROPOFOL 2%, PROPOFOL 1%, ROCURONIUM, SUGAMMADEX, BOTULINUM TOXIN TYPE A 50 UNITS, BOTULINUM TOXIN TYPE A 100 UNITS AND BOTULINUM TOXIN TYPE A 500 UNITS FOR THE CENTERS DEPENDENT ON THE MURCIAN HEALTH SERVICE.
SUGAMMADEXSUPPLY OF MEDICINES WITH ACTIVE INGREDIENTS CISATRACURIUM 2 MG/ML, PARENTERAL DEXKETOPROFEN, PARENTERAL FENTANYL, FLUMAZENIL, IRON SUCROSE, PARENTERAL LACOSAMIDE, LEVOSIMENDAN, NOREPINEPHRINE, MONTHLY INTRAMUSCULAR PALIPERIDONE, PARACETAMOL 1000 MG PARENTERAL, PROPOFOL 2%, PROPOFOL 1%, ROCURONIUM, SUGAMMADEX, BOTULINUM TOXIN TYPE A 50 UNITS, BOTULINUM TOXIN TYPE A 100 UNITS AND BOTULINUM TOXIN TYPE A 500 UNITS FOR THE CENTERS DEPENDENT ON THE MURCIAN HEALTH SERVICE.
BOTULINUM TOXIN TYPE A 50 UNITSSUPPLY OF MEDICINES WITH ACTIVE INGREDIENTS CISATRACURIUM 2 MG/ML, PARENTERAL DEXKETOPROFEN, PARENTERAL FENTANYL, FLUMAZENIL, IRON SUCROSE, PARENTERAL LACOSAMIDE, LEVOSIMENDAN, NOREPINEPHRINE, MONTHLY INTRAMUSCULAR PALIPERIDONE, PARACETAMOL 1000 MG PARENTERAL, PROPOFOL 2%, PROPOFOL 1%, ROCURONIUM, SUGAMMADEX, BOTULINUM TOXIN TYPE A 50 UNITS, BOTULINUM TOXIN TYPE A 100 UNITS AND BOTULINUM TOXIN TYPE A 500 UNITS FOR THE CENTERS DEPENDENT ON THE MURCIAN HEALTH SERVICE.
BOTULINUM TOXIN TYPE A 100 UNITSSUPPLY OF MEDICINES WITH ACTIVE INGREDIENTS CISATRACURIUM 2 MG/ML, PARENTERAL DEXKETOPROFEN, PARENTERAL FENTANYL, FLUMAZENIL, IRON SUCROSE, PARENTERAL LACOSAMIDE, LEVOSIMENDAN, NOREPINEPHRINE, MONTHLY INTRAMUSCULAR PALIPERIDONE, PARACETAMOL 1000 MG PARENTERAL, PROPOFOL 2%, PROPOFOL 1%, ROCURONIUM, SUGAMMADEX, BOTULINUM TOXIN TYPE A 50 UNITS, BOTULINUM TOXIN TYPE A 100 UNITS AND BOTULINUM TOXIN TYPE A 500 UNITS FOR THE CENTERS DEPENDENT ON THE MURCIAN HEALTH SERVICE.
BOTULINUM TOXIN TYPE A 500 UNITSSUPPLY OF MEDICINES WITH ACTIVE INGREDIENTS CISATRACURIUM 2 MG/ML, PARENTERAL DEXKETOPROFEN, PARENTERAL FENTANYL, FLUMAZENIL, IRON SUCROSE, PARENTERAL LACOSAMIDE, LEVOSIMENDAN, NOREPINEPHRINE, MONTHLY INTRAMUSCULAR PALIPERIDONE, PARACETAMOL 1000 MG PARENTERAL, PROPOFOL 2%, PROPOFOL 1%, ROCURONIUM, SUGAMMADEX, BOTULINUM TOXIN TYPE A 50 UNITS, BOTULINUM TOXIN TYPE A 100 UNITS AND BOTULINUM TOXIN TYPE A 500 UNITS FOR THE CENTERS DEPENDENT ON THE MURCIAN HEALTH SERVICE.
PARENTERAL DEXKETOPROFENSUPPLY OF MEDICINES WITH ACTIVE INGREDIENTS CISATRACURIUM 2 MG/ML, PARENTERAL DEXKETOPROFEN, PARENTERAL FENTANYL, FLUMAZENIL, IRON SUCROSE, PARENTERAL LACOSAMIDE, LEVOSIMENDAN, NOREPINEPHRINE, MONTHLY INTRAMUSCULAR PALIPERIDONE, PARACETAMOL 1000 MG PARENTERAL, PROPOFOL 2%, PROPOFOL 1%, ROCURONIUM, SUGAMMADEX, BOTULINUM TOXIN TYPE A 50 UNITS, BOTULINUM TOXIN TYPE A 100 UNITS AND BOTULINUM TOXIN TYPE A 500 UNITS FOR THE CENTERS DEPENDENT ON THE MURCIAN HEALTH SERVICE.
PARENTERAL FENTANYLSUPPLY OF MEDICINES WITH ACTIVE INGREDIENTS CISATRACURIUM 2 MG/ML, PARENTERAL DEXKETOPROFEN, PARENTERAL FENTANYL, FLUMAZENIL, IRON SUCROSE, PARENTERAL LACOSAMIDE, LEVOSIMENDAN, NOREPINEPHRINE, MONTHLY INTRAMUSCULAR PALIPERIDONE, PARACETAMOL 1000 MG PARENTERAL, PROPOFOL 2%, PROPOFOL 1%, ROCURONIUM, SUGAMMADEX, BOTULINUM TOXIN TYPE A 50 UNITS, BOTULINUM TOXIN TYPE A 100 UNITS AND BOTULINUM TOXIN TYPE A 500 UNITS FOR THE CENTERS DEPENDENT ON THE MURCIAN HEALTH SERVICE.
FLUMAZENILSUPPLY OF MEDICINES WITH ACTIVE INGREDIENTS CISATRACURIUM 2 MG/ML, PARENTERAL DEXKETOPROFEN, PARENTERAL FENTANYL, FLUMAZENIL, IRON SUCROSE, PARENTERAL LACOSAMIDE, LEVOSIMENDAN, NOREPINEPHRINE, MONTHLY INTRAMUSCULAR PALIPERIDONE, PARACETAMOL 1000 MG PARENTERAL, PROPOFOL 2%, PROPOFOL 1%, ROCURONIUM, SUGAMMADEX, BOTULINUM TOXIN TYPE A 50 UNITS, BOTULINUM TOXIN TYPE A 100 UNITS AND BOTULINUM TOXIN TYPE A 500 UNITS FOR THE CENTERS DEPENDENT ON THE MURCIAN HEALTH SERVICE.
iron sucroseSUPPLY OF MEDICINES WITH ACTIVE INGREDIENTS CISATRACURIUM 2 MG/ML, PARENTERAL DEXKETOPROFEN, PARENTERAL FENTANYL, FLUMAZENIL, IRON SUCROSE, PARENTERAL LACOSAMIDE, LEVOSIMENDAN, NOREPINEPHRINE, MONTHLY INTRAMUSCULAR PALIPERIDONE, PARACETAMOL 1000 MG PARENTERAL, PROPOFOL 2%, PROPOFOL 1%, ROCURONIUM, SUGAMMADEX, BOTULINUM TOXIN TYPE A 50 UNITS, BOTULINUM TOXIN TYPE A 100 UNITS AND BOTULINUM TOXIN TYPE A 500 UNITS FOR THE CENTERS DEPENDENT ON THE MURCIAN HEALTH SERVICE.
PARENTERAL LACOSAMIDESUPPLY OF MEDICINES WITH ACTIVE INGREDIENTS CISATRACURIUM 2 MG/ML, PARENTERAL DEXKETOPROFEN, PARENTERAL FENTANYL, FLUMAZENIL, IRON SUCROSE, PARENTERAL LACOSAMIDE, LEVOSIMENDAN, NOREPINEPHRINE, MONTHLY INTRAMUSCULAR PALIPERIDONE, PARACETAMOL 1000 MG PARENTERAL, PROPOFOL 2%, PROPOFOL 1%, ROCURONIUM, SUGAMMADEX, BOTULINUM TOXIN TYPE A 50 UNITS, BOTULINUM TOXIN TYPE A 100 UNITS AND BOTULINUM TOXIN TYPE A 500 UNITS FOR THE CENTERS DEPENDENT ON THE MURCIAN HEALTH SERVICE.
LEVOSIMENDANSUPPLY OF MEDICINES WITH ACTIVE INGREDIENTS CISATRACURIUM 2 MG/ML, PARENTERAL DEXKETOPROFEN, PARENTERAL FENTANYL, FLUMAZENIL, IRON SUCROSE, PARENTERAL LACOSAMIDE, LEVOSIMENDAN, NOREPINEPHRINE, MONTHLY INTRAMUSCULAR PALIPERIDONE, PARACETAMOL 1000 MG PARENTERAL, PROPOFOL 2%, PROPOFOL 1%, ROCURONIUM, SUGAMMADEX, BOTULINUM TOXIN TYPE A 50 UNITS, BOTULINUM TOXIN TYPE A 100 UNITS AND BOTULINUM TOXIN TYPE A 500 UNITS FOR THE CENTERS DEPENDENT ON THE MURCIAN HEALTH SERVICE.
NOREPINEPHRINESUPPLY OF MEDICINES WITH ACTIVE INGREDIENTS CISATRACURIUM 2 MG/ML, PARENTERAL DEXKETOPROFEN, PARENTERAL FENTANYL, FLUMAZENIL, IRON SUCROSE, PARENTERAL LACOSAMIDE, LEVOSIMENDAN, NOREPINEPHRINE, MONTHLY INTRAMUSCULAR PALIPERIDONE, PARACETAMOL 1000 MG PARENTERAL, PROPOFOL 2%, PROPOFOL 1%, ROCURONIUM, SUGAMMADEX, BOTULINUM TOXIN TYPE A 50 UNITS, BOTULINUM TOXIN TYPE A 100 UNITS AND BOTULINUM TOXIN TYPE A 500 UNITS FOR THE CENTERS DEPENDENT ON THE MURCIAN HEALTH SERVICE.
MENSUAL INTRAMUSCULAR PALIPERIDONESUPPLY OF MEDICINES WITH ACTIVE INGREDIENTS CISATRACURIUM 2 MG/ML, PARENTERAL DEXKETOPROFEN, PARENTERAL FENTANYL, FLUMAZENIL, IRON SUCROSE, PARENTERAL LACOSAMIDE, LEVOSIMENDAN, NOREPINEPHRINE, MONTHLY INTRAMUSCULAR PALIPERIDONE, PARACETAMOL 1000 MG PARENTERAL, PROPOFOL 2%, PROPOFOL 1%, ROCURONIUM, SUGAMMADEX, BOTULINUM TOXIN TYPE A 50 UNITS, BOTULINUM TOXIN TYPE A 100 UNITS AND BOTULINUM TOXIN TYPE A 500 UNITS FOR THE CENTERS DEPENDENT ON THE MURCIAN HEALTH SERVICE.